Pediatrics
News
Antiretroviral pill better at suppressing HIV in children
The pill-based regimen reduced the chances of treatment failure among children aged 3-18 by about 40%, compared with other treatments.
News
Pandemic screen time linked to anxiety, depression in older kids
But the new research doesn’t prove that screen time is harmful.
News
FDA to review PDE4-inhibitor roflumilast for psoriasis
The target action date for approval for the topical psoriasis treatment is in July 2022.
Conference Coverage
AD burden may be greater for those with head, neck, face, and hand involvement
“These findings highlight the importance of detailed assessment of specific areas affected by AD to personalize treatment approaches to the needs...
News
iPLEDGE rollout: As frustration mounts, FDA agrees to help solve issues
American Academy of Dermatology Association representatives described the severe impact on patient access to treatment.
News from the FDA/CDC
Children and COVID: New cases up slightly, vaccinations continue to slow
The number of COVID-related deaths in children is now four digits.
News
RSV resurgence likely in wake of COVID-19
Model suggests that RSV hospitalizations in young children may double from typical levels in 2021-2022.
News
Pfizer COVID vaccine for younger children hits snag
Pfizer reported that its 3-microgram dose generated a protective immune response in those aged 6-24 months but didn’t generate adequate immunity...
News
Advisory on youth mental health crisis gets mixed reviews
One in five U.S. children and adolescents aged 3-17 suffer from a mental, emotional, developmental, or behavioral disorder.
News
A pandemic silver lining? Dramatic drop in teen drug use
The latest findings, from the Monitoring the Future survey, represent the largest 1-year decrease in overall illicit drug use reported since the...